These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 27631178

  • 1. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H, Agah S, Mousavi SN, Hosseini AF, Shidfar F.
    Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
    Dabbaghmanesh MH, Danafar F, Eshraghian A, Omrani GR.
    Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
    Mahmoudi L, Asadi S, Al-Mousavi Z, Niknam R.
    Clin Nutr; 2021 May; 40(5):2999-3005. PubMed ID: 33341312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, Vaghef-Mehrabany E, Aliashrafi S.
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [Abstract] [Full Text] [Related]

  • 8. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Samimi M, Jamilian M, Asemi Z, Esmaillzadeh A.
    Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
    [Abstract] [Full Text] [Related]

  • 9. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
    Nikbaf-Shandiz M, Tutunchi H, Khoshbaten M, Nazari Bonab H, Ebrahimi-Mameghani M.
    Food Funct; 2022 Nov 14; 13(22):11568-11578. PubMed ID: 36263703
    [Abstract] [Full Text] [Related]

  • 10. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F, Adibi P, Hekmatdoost A.
    Br J Nutr; 2015 Sep 14; 114(5):796-803. PubMed ID: 26234526
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.
    BMC Complement Altern Med; 2019 Mar 12; 19(1):59. PubMed ID: 30871514
    [Abstract] [Full Text] [Related]

  • 14. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients.
    Hussain M, Iqbal J, Malik SA, Waheed A, Shabnum S, Akhtar L, Saeed H.
    Pak J Pharm Sci; 2019 May 12; 32(3 Special):1343-1348. PubMed ID: 31551213
    [Abstract] [Full Text] [Related]

  • 15. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, Saulle R, Perri L, Morini S, Tiberti C, Bertoccini L, Cimini FA, Panimolle F, Catalano C, Baroni MG, Cavallo MG.
    BMC Med; 2016 Jun 29; 14():92. PubMed ID: 27353492
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF, Wang C, Yang T, Li S, Li KL, Li D.
    Food Funct; 2020 Sep 23; 11(9):7389-7399. PubMed ID: 32966467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.